205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28-30 March 2014, Naarden, The Netherlands

Neuromuscular Disorders

Volumn 25, Issue 3, 2015, Pages 268-272

  De Bleecker, Jan L ^a   De Paepe, Boel ^a   Aronica, Eleonora ^b   de Visser, Marianne ^b   Amato, Anthony ^c   Benveniste, Olivier ^d   De Bleecker, Jan ^a   De Boer, Onno ^b   Dimachkie, Mazen ^e   Gherardi, Romain ^f   Goebel, Hans Hilmar ^g   Hilton Jones, David ^h   Holton, Janice ⁱ   Lundberg, Ingrid E ^j   Mammen, Andrew ^k   Mastaglia, Frank ^l   Nishino, Ichizo ^m   Rushing, Elisabeth ⁿ   Daa Schroder, Henrik ^o   Selcen, Duygu ^p   Stenzel, Werner ^q   more..

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c HARVARD MEDICAL SCHOOL   (United States)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^f UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^h JOHN RADCLIFFE HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j KAROLINSKA INSTITUTE   (Sweden)

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^m NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

ⁿ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^o ODENSE UNIVERSITY HOSPITAL   (Denmark)

^p MAYO CLINIC   (United States)

^q CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONSENSUS DEVELOPMENT; DERMATOMYOSITIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INCLUSION BODY MYOSITIS; MUSCLE BIOPSY; MYOSITIS; NETHERLANDS; PATHOLOGY; POLYMYOSITIS; PRIORITY JOURNAL; SCORING SYSTEM; WORKSHOP; BIOPSY; CLASSIFICATION; CONSENSUS; MUSCLE; PROCEDURES;

COLORING AGENT;

BIOPSY; COLORING AGENTS; CONSENSUS; HUMANS; MUSCLES; MYOSITIS; NETHERLANDS;

EID: 84924337345     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2014.12.001     Document Type: Article

References (25)

1. De Bleecker J.L., Lundberg I.E., de Visser M. 193rd ENMC International Workshop Pathology Diagnosis of Idiopathic Inflammatory Myopathies 30 November - 2 December 2012, Naarden, The Netherlands. Neuromuscul Disord 2013, 23:945-951. ENMC Myositis Muscle Biopsy Study Group.
2. Carpenter S., Karpati G., Keller I., Eisen A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 1978, 28:8-17.
3. Griggs R.C., Mendell J.R., Miller R.F. Evaluation and treatment of myopathies 1995, Davis.
4. Verschuuren J.J., Van Engelen B.G.M., Van Der Hoeven J., et al. Inclusion body myositis. Diagnostic criteria for neuromuscular disorders 1997, 81-84. Royal Society of Medicine, London. A. Emery (Ed.).
5. Benveniste O., Hilton-Jones D. International Workshop of Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. Neuromuscul Disord 2010, 20:414-421.
6. Rose M. 188th ENMC International Workshop: inclusion body myositis, 2-4 December 2011, Naarden, The Netherlands. Neuromuscul Disord 2013, 23:1044-1055.
7. Benveniste O., Guiguet M., Freebody J., et al. Long-term observational study of sporadic inclusion body myositis. Brain 2011, 134:3176-3184.
8. Cox F., Titulaer M., Sont J., et al. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain 2011, 134:3167-3175.
9. Brady S., Squier W., Hilton-Jones D. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. J Neurol Neurosurg Psychiatry 2013, 84:1240-1246.
10. Chahin N., Engel A.G. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 2008, 70:418-424.
11. Askanas V., Engel A., Nogalska A. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis. J Neuropathol Exp Neurol 2012, 71:680-693.
12. Dubourg O., Wanschitz J., Maisonobe T., et al. Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis. Acta Myol 2011, 30:103-108.
13. Brady S., Squier W., Sewry C., Hanna M., Hilton-Jones D., Holton J. A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis. BMJ Open 2014, 4. e004552.
14. Pluk H., van Hoeve B., van Dooren S., et al. Autoantibodies to cytosolic 5'-nucleotidase IA in inclusion body myositis. Ann Neurol 2013, 73:397-407.
15. Larman H., Salajegheh M., Nazareno R., et al. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann Neurol 2013, 73:408-418.
16. Bohan A., Peter J.B. Polymyositis and dermatomyositis. N Engl J Med 1975, 292:344-347.
17. Bohan A., Peter J.B. Polymyositis and dermatomyositis. N Engl J Med 1975, 292:403-407.
18. Dalakas M.C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003, 362:971-982.
19. Van der Meulen M.F.G., Bronner M., Hoogendijk J.E., et al. Polymyositis: a diagnostic entity reconsidered. Neurology 2003, 61:316-321.
20. Hoogendijk J.E., Amato A.A., Lecky B.R., et al. 119th ENMC International Workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004, 14:337-345.
21. Miller F.W., Rider L.G., Plotz P.H., et al. Polymyositis: an overdiagnosed entity. Neurology 2004, 63:402-403.
22. Hilton-Jones D. Observations on the classification of the inflammatory myopathies. Presse Med 2011, 40:e199-e208.
23. Pestronk A. Acquired immune and inflammatory myopathies: pathologic classification. Curr Opin Rheumatol 2011, 23:595-604.
24. Wedderburn L.R., Varsani H., Charles K.C., et al. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 2007, 57:1192-1201.
25. Varsani H., Charman S.C., Li C.K., et al. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Ann Rheum Dis 2013, 10.1136/annrheumdis-2013-203396.